Advanced blood-based diagnostics for brain injuries
Identify LVO stroke patients for timely treatment; Differentiate between ischemic and hemorrhagic strokes; Detect mild traumatic brain injuries quickly; Validate novel brain biomarkers for clinical use; Enhance regulatory compliance for diagnostic solutions.
Notable partnership with Minosia for AI-supported regulatory compliance; Founders recognized as Key Opinion Leaders in brain biomarkers; Based in Switzerland with a focus on point-of-care diagnostics.
Contact & Links
Key Information
Company Context